MENXF yields 2000000.00% · MRK yields 2.76%● Live data
📍 MENXF pulled ahead of the other in Year 1
Combined, MENXF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MENXF + MRK for your $10,000?
Memex Inc. develops, commercializes, and manufactures a suite of products for its customers in the discrete manufacturing and aerospace sectors worldwide. The company primarily offers MERLIN Tempus, a software-driven industrial Internet of Things communications platform that provides manufacturing productivity metrics, including overall equipment effectiveness in real time. Its MERLIN Tempus measures and analyzes manufacturing and production performance, and provides its users with real-time insights on operational efficiency. The company also provides MERLIN Tempus Enterprise Edition for enhancing the value of time with enterprise resource planning connectivity and job scheduling; MERLIN financial Overall Equipment Effectiveness (FOEE), which enables factory organizations to link their shop floor performance to actual profit dollars; MERLIN Continuous Improvement (CI) Fast-track services, a nine-step implementation process; and MERLIN Operator Portal, a Windows based human machine interface (HMI) that provides operators with a live window into what information is being collected from the machines in real-time. In addition, the company provides MERLIN Enterprise Resource Planning connector, a bi-synchronous interface; MERLIN OPTime to assess, measure, identify, and optimize data-driven manufacturing; and SCANGun, a bar code scanner. Further, it offers IIoT hardware solutions, including MERLIN MTC-One that incorporate sensor-based process-driven data; MTConnect hardware adapter, which enables machine tool to communicate critical operational information using the MTConnect standard protocol; software adapters; and DNC memory upgrade products. Memex Inc. was founded in 1992 and is headquartered in Burlington, Canada.
Full MENXF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.